In the present study, the corrected QT interval (QTc) was measured in a healthy sample in Changsha, China. The findings were that the peak incidences of long and short QTc existed in two separate groups in the healthy sample.
Objective: To analyse the incidence of long and short corrected QT (QTc) in a healthy sample of the population of Changsha in China.
A traditional Chinese medicine pancreas-cleansing clog-removing formula effectively prolonged the survival of patients with pancreatic cancer and inhibited the proliferation of tumour cells, thus being worthy of promotion in clinical practice.
Objectives: To evaluate the performance of a traditional Chinese medicine pancreas-cleansing, clog-removing (Qiyi Huaji, QYHJ) formula in prolonging survival of pancreatic cancer (PC), stabilizing tumor growth, and inhibiting tumour cell proliferation.
Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.
Pathogenesis of peri-implantitis remains largely unknown. In this study, we have used salivary and tissue samples of patients with peri-implantitis and have highlighted a significant role for oxidative stress and advanced glycation end products in the pathogenesis.
We report a case of successful treatment with erlotinib of a patient with non-small cell lung cancer (stage IV) and meningeal metastasis. Combined treatment with whole brain radiotherapy (WBRT) and erlotinib mitigated neurologic symptoms of the patient. Magnetic resonance imaging showed reduction of the brain metastasis. Partial remission was observed by chest computed tomography (CT) scan after six months of erlotinib therapy.